Reltecimod TFA
Product Specifications
Target
Immunology/Inflammation related, Antibacterial
Related Pathways
Microbiology/Virology, Immunology/Inflammation
Purity
0.9978
Bioactivity
Reltecimod TFA (AB-103 TFA) is a CD28 (T-lymphocyte receptor) mimetic that acts as a CD28 antagonist, inhibiting the stimulation of t-cells by a range of bacterial pathogens thereby attenuating acute inflammation for the treatment of necrotizing soft tissue infections (NSTI) .
Smiles
[H]N[C@@H](C)C(N[C@H](C(N1CCC[C@H]1C(N[C@@H](CCSC)C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)C(C)C)=O)CC(C)C)=O)=O)=O)CO)=O.OC(C(F)(F)F)=O
Molecular Formula
C48H73F3N10O17S
Molecular Weight
1151.21
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC101748-01 250 mg
3,5-Dichloro-N- ((1- ((2,2-dimethyltetrahydro-2H-pyran-4-yl) methyl) -4-fluoropiperidin-4-yl) methyl) benzamide
Sign In for Pricing
View Details PC101748-02 1 g
3,5-Dichloro-N- ((1- ((2,2-dimethyltetrahydro-2H-pyran-4-yl) methyl) -4-fluoropiperidin-4-yl) methyl) benzamide
Sign In for Pricing
View Details